Literature DB >> 16441243

Epileptogenesis and rational therapeutic strategies.

H Stefan1, F H Lopes da Silva, W Löscher, D Schmidt, E Perucca, M J Brodie, P A J M Boon, W H Theodore, S L Moshé.   

Abstract

The understanding of neurobiological mechanisms of epileptogenesis is essential for rational approaches for a possible disease modification as well as treatment of underlying causes of the epilepsies. More effort is necessary to translate results from basic investigations into new approaches for clinical research and to better understand a relationship with findings from clinical studies. The following report is a condensed synapsis in which molecular mechanisms of epileptogenesis, pharmacological modulation of epileptogenesis, evidence based therapy, refractoriness and prediction of outcome is provided in order to stimulate further collaborative international research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441243     DOI: 10.1111/j.1600-0404.2005.00561.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  15 in total

1.  Non-linear classification of heart rate parameters as a biomarker for epileptogenesis.

Authors:  Farshad Kheiri; Anatol Bragin; Jerome Engel; Joel Almajano; Eamon Winden
Journal:  Epilepsy Res       Date:  2012-02-02       Impact factor: 3.045

Review 2.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice.

Authors:  Ursula S Sandau; Mayadah Yahya; Ryan Bigej; Joseph L Friedman; Bounmy Saleumvong; Detlev Boison
Journal:  Epilepsia       Date:  2019-02-27       Impact factor: 5.864

4.  Towards a non-invasive interictal application of hypothermia for treating seizures: a feasibility and pilot study.

Authors:  A Bagić; W H Theodore; E A Boudreau; R Bonwetsch; J Greenfield; W Elkins; S Sato
Journal:  Acta Neurol Scand       Date:  2008-03-18       Impact factor: 3.209

Review 5.  Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

Authors:  Cecilie Johannessen Landmark
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Coenzyme q10 ameliorates neurodegeneration, mossy fiber sprouting, and oxidative stress in intrahippocampal kainate model of temporal lobe epilepsy in rat.

Authors:  Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  J Mol Neurosci       Date:  2012-09-25       Impact factor: 3.444

7.  5-HT6 Receptor Recruitment of mTOR Modulates Seizure Activity in Epilepsy.

Authors:  Liang Wang; Yaodong Lv; Wanni Deng; Xi Peng; Zheng Xiao; Zhiqin Xi; Guojun Chen; Xuefeng Wang
Journal:  Mol Neurobiol       Date:  2014-07-18       Impact factor: 5.590

Review 8.  Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

Review 9.  Stabilizing dendritic structure as a novel therapeutic approach for epilepsy.

Authors:  Michael Wong
Journal:  Expert Rev Neurother       Date:  2008-06       Impact factor: 4.618

10.  Antiepileptic drug monotherapy: the initial approach in epilepsy management.

Authors:  Erik K St Louis; William E Rosenfeld; Thomas Bramley
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.